Pharmaceutical

SIGA’s antiviral approved in Japan for orthopoxvirus treatment

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

Jan 4, 2025 - 06:00
SIGA’s antiviral approved in Japan for orthopoxvirus treatment
SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.
Read the original article

Tags:

Previous Article

From Davids to Goliaths: the GLP-1RA gold rush

Next Article

China’s NMPA prioritises HUTCHMED’s lung cancer therapy review

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BioNTech targets infectious diseases for vaccine development

BioNTech targets infectious diseases for vaccine develo...

Mar 29, 2023

STAT+: Juul spent big to court Black leaders to promote its e-cigarettes, new documents show

STAT+: Juul spent big to court Black leaders to promote...

Feb 3, 2024

Be Bio raises $82m to advance haemophilia B gene therapy to Phase I/II trial

Be Bio raises $82m to advance haemophilia B gene therap...

Oct 24, 2024